Age-Related Epigenetic Changes May Lead to Development of Diabetes in Later Life
By LabMedica International staff writers Posted on 11 Apr 2016 |
Image: Pancreatic islets, shown as the lighter tissue among the darker, acinar pancreatic tissue in this hemalum-eosin stained slide (Photo courtesy of Wikimedia Commons).
Epigenetic changes that cause increased methylation and partial or complete inactivation of genes during aging may contribute to the development of type II diabetes in older individuals.
Investigators at Lund University (Malmö, Sweden) examined whether age-related epigenetic changes affected human islet function and if blood-based epigenetic biomarkers reflected those changes and were linked to the future appearance of type II diabetes. To accomplish this task, they analyzed DNA methylation in the genomes of pancreatic islet cells obtained from 87 non-diabetic donors, aged 26–74 years.
They reported in the March 31, 2016, online edition of the journal Nature Communications that aging was associated with increased DNA methylation of 241 sites. These sites covered genetic loci previously associated with type II diabetes, for example, KLF14 (Krüppel-like factor 14). Blood-based epigenetic biomarkers reflected age-related methylation changes in 83 genes identified in human islets (for example, KLF14, FHL2 (Four and a half LIM domains 2), ZNF518B (Zinc finger protein 518B), and FAM123C (APC membrane recruitment protein 3). Some of these proteins were linked to insulin secretion and type II diabetes. Silencing these genes in beta-cells altered – often increasing – insulin secretion.
"Increased insulin secretion actually protects against type II diabetes. It could be the body's way of protecting itself when other tissue becomes resistant to insulin, which often happens as we get older", said senior author Dr. Charlotte Ling, professor of clinical science at Lund University. "You cannot change your genes and the risks that they entail, but epigenetics means that you can affect the DNA methylations, and thereby gene activity, through lifestyle choices."
Related Links:
Lund University
Investigators at Lund University (Malmö, Sweden) examined whether age-related epigenetic changes affected human islet function and if blood-based epigenetic biomarkers reflected those changes and were linked to the future appearance of type II diabetes. To accomplish this task, they analyzed DNA methylation in the genomes of pancreatic islet cells obtained from 87 non-diabetic donors, aged 26–74 years.
They reported in the March 31, 2016, online edition of the journal Nature Communications that aging was associated with increased DNA methylation of 241 sites. These sites covered genetic loci previously associated with type II diabetes, for example, KLF14 (Krüppel-like factor 14). Blood-based epigenetic biomarkers reflected age-related methylation changes in 83 genes identified in human islets (for example, KLF14, FHL2 (Four and a half LIM domains 2), ZNF518B (Zinc finger protein 518B), and FAM123C (APC membrane recruitment protein 3). Some of these proteins were linked to insulin secretion and type II diabetes. Silencing these genes in beta-cells altered – often increasing – insulin secretion.
"Increased insulin secretion actually protects against type II diabetes. It could be the body's way of protecting itself when other tissue becomes resistant to insulin, which often happens as we get older", said senior author Dr. Charlotte Ling, professor of clinical science at Lund University. "You cannot change your genes and the risks that they entail, but epigenetics means that you can affect the DNA methylations, and thereby gene activity, through lifestyle choices."
Related Links:
Lund University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples